Clinical trial
Natural History Study of Patients With Chronic Myelogenous Leukemia
NCT00429910 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00429910 |
|---|---|
| Title | Natural History Study of Patients With Chronic Myelogenous Leukemia |
| Official title | Chronic Myeloid Leukemia (CML) Cohort |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Leukemia |
| Enrollment | 48 |
| Start date | Feb 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Feb 1, 2007 |
| Last update posted | Jan 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: